PEDIATRICS Vol. 96 No. 2 August 1995, pp. 259-264
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, T. A.
Right arrow Articles by Little, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, T. A.
Right arrow Articles by Little, B.

Neurologic Manifestations of In Utero Cocaine Exposure in Near-Term and Term Infants

Terri A. King DO1, Jeffrey M. Perlman MB2, Abbot R. Laptook MD2, Nancy Rollins MD3, Gregory Jackson MD1, and Bertis Little PhD4

1 Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas
2 Departments of Pediatrics, Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas
3 Department of Radiology, University of Texas Southwestern Medical Center, Dallas
4 Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas

Objective. To determine whether the incidence of neurosonographic and neurologic abnormalities is higher in cocaine-exposed infants at birth.

Methods. In utero exposure to cocaine was investigated in 39 term and near-term infants with positive urine screens for cocaine only and 39 matched control infants without drug exposure admitted to the regular term newborn nursery. Serial evaluations were performed on each infant on postnatal days 1 and 2 and included a cranial sonogram, a neurologic and behavioral assessment for drug withdrawal, and Doppler interrogation of the anterior and middle cerebral arteries.

Results. There were no differences between groups in neurosonographic abnormalities. Grade I or II intraventricular hemorrhage occurred in 11% of cocaine-exposed and 11% of control infants. There were no cases of grade III intraventricular hemorrhage, cystic periventricular leukomalacia, or neonatal stroke. Head size was smaller in cocaine-exposed infants, ie, 32.7 ± 0.1 cm versus 33.8 ± 0.1 cm. The neurologic examination was similar between groups with regard to tone, reflexes, and cranial nerves. Behavioral scores were higher on both days, in cocaine-exposed versus control infants, ie, 4.4 ± 0.5 versus 2.7 ± 0.3 on day 1 and 5.0 ± 0.5 versus 1.71 ± 0.31 on day 2. Cerebral blood flow velocity measurements in the anterior cerebral artery were similar between groups on both days of examination. However, cocaine-exposed infants demonstrated a significant increase in flow velocity from day 1 to day 2, ie, 0.48 ± 0.03 to 0.57 ± 0.04. There was a concomitant decrease in the pulsatility index from day 1 to day 2 in the cocaine-exposed, ie, 0.74 ± 0.02 to 0.69 ± 0.02, but not in the control infants. No differences were noted in the flow velocities in the middle cerebral arteries between groups.

Conclusions. Term and near-term infants admitted to a regular nursery who are exposed to cocaine in utero: (1) do not exhibit an increased incidence of neurosonographic abnormalities; (2) do exhibit altered behavior consistent with drug withdrawal; and (3) do demonstrate changes in flow velocity in the anterior cerebral artery consistent with the vasoconstrictive effects of the drug. However, these changes were not accompanied by changes in the neurologic examination or altered care. The long-term neurodevelopmental implications of these subtle abnormalities in the neonatal period remain to be determined.

Submitted on June 27, 1994
Accepted on November 3, 1994




This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
C. R. Bauer, J. C. Langer, S. Shankaran, H. S. Bada, B. Lester, L. L. Wright, H. Krause-Steinrauf, V. L. Smeriglio, L. P. Finnegan, P. L. Maza, et al.
Acute Neonatal Effects of Cocaine Exposure During Pregnancy
Arch Pediatr Adolesc Med, September 1, 2005; 159(9): 824 - 834.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
K Johnson, C Gerada, and A Greenough
Treatment of neonatal abstinence syndrome
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2003; 88(1): F2 - 5.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. A. Frank, K. M. McCarten, C. D. Robson, M. Mirochnick, H. Cabral, H. Park, and B. Zuckerman
Level of In Utero Cocaine Exposure and Neonatal Ultrasound Findings
Pediatrics, November 1, 1999; 104(5): 1101 - 1105.
[Abstract] [Full Text]


Home page
Arch Pediatr Adolesc MedHome page
K. J. S. Anand, N. McIntosh, H. Lagercrantz, E. Pelausa, T. E. Young, and R. Vasa
Analgesia and Sedation in Preterm Neonates Who Require Ventilatory Support: Results From the NOPAIN Trial
Arch Pediatr Adolesc Med, April 1, 1999; 153(4): 331 - 338.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
F. D. Eyler, M. Behnke, M. Conlon, N. S. Woods, and K. Wobie
Birth Outcome From a Prospective, Matched Study of Prenatal Crack/Cocaine Use: I. Interactive and Dose Effects on Health and Growth
Pediatrics, February 1, 1998; 101(2): 229 - 236.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
N. P. Rosman and D. J. Roberts
Case 15-1997- Respiratory Distress and Seizure in a Neonate
N. Engl. J. Med., May 15, 1997; 336(20): 1439 - 1446.
[Full Text] [PDF]